US Stock MarketDetailed Quotes

SAGE Sage Therapeutics

Watchlist
  • 5.540
  • -0.190-3.32%
Close Dec 27 16:00 ET
  • 5.540
  • 0.0000.00%
Post 20:01 ET
338.90MMarket Cap-0.99P/E (TTM)

Sage Therapeutics Key Stats

Sage Therapeutics Q3 2024 Earnings Date

Currency:USDOct 29, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
10.85M
11.87M
+1.02M
Beat Est.
+299.62%
+337.08%
+9.37%
EPS
-1.54
-1.53
+<0.01
Beat Est.
+54.38%
+54.60%
+0.47%
Hold

Dec 28, 2024

Sage Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 16.167M--
--2024/Q4-- / 13.970M--
Oct 29, 20242024/Q311.871M / 10.854M--
Jul 31, 20242024/Q28.654M / 8.867M--
Apr 25, 20242024/Q17.902M / 5.187M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 16.167M--
--2024/Q4-- / 13.970M--
Oct 29, 20242024/Q311.871M / 10.854M--
Jul 31, 20242024/Q28.654M / 8.867M--
Apr 25, 20242024/Q17.902M / 5.187M--

Unlock Free Earnings Estimates

Sage Therapeutics Earnings Reports

Read more

Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Analysis

Analyst Rating

Updated: Dec 28, 2024

Hold

  • Buy

    12.50%
  • Hold

    75.00%
  • Sell

    12.50%

Price Target

No Data